Next, we tested the anti-tumor efficacy of intravesical muAd-Ifnα treatment in the syngeneic MB49 BLCA model and compared it with vehicle-treated or Ad-Ctrl treated mice. The gene discussed is IFNA2; the disease is neoplasm.